Mardia Samyoung Capillary Tubes Co. Ltd.

As of June 30, 2026, Mardia Samyoung Capillary Tubes Co. Ltd. carries a market capitalization of 3.85B, placing it among publicly traded companies globally. Its enterprise value stands at 3.85B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Mardia Samyoung Capillary Tubes Co. Ltd. has 79.46M shares outstanding.

As of June 30, 2026, Mardia Samyoung Capillary Tubes Co. Ltd. trades at a trailing price-to-earnings ratio of 33.84.

As of June 30, 2026, Mardia Samyoung Capillary Tubes Co. Ltd. trades at an EV/EBITDA multiple of 75.02 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.90 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 75.04 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 3.85B versus a market cap of 3.85B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Mardia Samyoung Capillary Tubes Co. Ltd. recorded 16.30M in income tax expense. That works out to an effective tax rate of 31.74, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 51.36M, leaving 35.06M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Mardia Samyoung Capillary Tubes Co. Ltd.'s stock has declined approximately 52.09% over the past 52 weeks. The 50-day moving average sits at 55.55, while the 200-day moving average is 68.90.

Over the twelve months ended June 30, 2026, Mardia Samyoung Capillary Tubes Co. Ltd. generated 987.10M in revenue and converted that into 35.06M in net income, yielding earnings per share of 1.43. EBITDA reached 51.37M, while operating income came in at 51.36M.

Over the twelve months ended June 30, 2026, Mardia Samyoung Capillary Tubes Co. Ltd. posted a gross margin of 6.38, reflecting its pricing power and cost economics. The operating margin of 5.20 and net profit margin of 3.55 provide insight into operational efficiency.

Mardia Samyoung Capillary Tubes Co. Ltd.'s most recent stock split took place on March 20, 2014.